Tech Company Financing Transactions

Resolvyx Pharmaceuticals Funding Round

Atlas Venture, CHL Medical Partners and Flagship Pioneering participated in a $17 million Series A venture round for Resolvyx Pharmaceuticals. The round was announced on 12/9/2005.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

25 1st St.
Cambridge, MA 02141
USA

Phone

(781) 541-5045

Website

www.resolvyx.com

Email Address

[email protected]

Overview

Resolvyx is a biopharmaceutical company committed to the discovery and development of therapies based on the novel concept of inflammation resolution through activation of the body's own off-switch mechanisms.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Greg Weinhoff

        

Chief Executive Officer

James Nichols

        

Chief Medical Officer

Per Gjorstrup

        

Browse more venture capital transactions:

Prev: 12/8/2005: Pentadyne Power venture capital transaction
Next: 12/12/2005: Beceem Communications venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary